vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Sun Country Airlines Holdings, Inc. (SNCY). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $281.0M, roughly 1.8× Sun Country Airlines Holdings, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.9%, a 3.9% gap on every dollar of revenue. On growth, Sun Country Airlines Holdings, Inc. posted the faster year-over-year revenue change (7.9% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -5.0%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

Frontier Airlines, Inc. is a major American ultra low-cost airline headquartered in Denver, Colorado. It operates flights to over 120 destinations in the United States, the Caribbean, Mexico and Central America, and employs more than 5,000 staff. The carrier is a publicly traded company and maintains bases at Denver International Airport, Orlando International Airport, and eleven other cities across the contiguous United States and Puerto Rico.

MD vs SNCY — Head-to-Head

Bigger by revenue
MD
MD
1.8× larger
MD
$493.8M
$281.0M
SNCY
Growing faster (revenue YoY)
SNCY
SNCY
+9.6% gap
SNCY
7.9%
-1.7%
MD
Higher net margin
MD
MD
3.9% more per $
MD
6.8%
2.9%
SNCY
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-5.0%
SNCY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
SNCY
SNCY
Revenue
$493.8M
$281.0M
Net Profit
$33.7M
$8.1M
Gross Margin
Operating Margin
9.9%
6.5%
Net Margin
6.8%
2.9%
Revenue YoY
-1.7%
7.9%
Net Profit YoY
10.5%
-39.4%
EPS (diluted)
$0.40
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
SNCY
SNCY
Q4 25
$493.8M
$281.0M
Q3 25
$492.9M
$255.5M
Q2 25
$468.8M
$263.6M
Q1 25
$458.4M
$326.6M
Q4 24
$502.4M
$260.4M
Q3 24
$511.2M
$249.5M
Q2 24
$504.3M
$254.4M
Q1 24
$495.1M
$311.5M
Net Profit
MD
MD
SNCY
SNCY
Q4 25
$33.7M
$8.1M
Q3 25
$71.7M
$1.6M
Q2 25
$39.3M
$6.6M
Q1 25
$20.7M
$36.5M
Q4 24
$30.5M
$13.4M
Q3 24
$19.4M
$2.3M
Q2 24
$-153.0M
$1.8M
Q1 24
$4.0M
$35.3M
Operating Margin
MD
MD
SNCY
SNCY
Q4 25
9.9%
6.5%
Q3 25
13.8%
3.9%
Q2 25
12.8%
6.2%
Q1 25
7.0%
17.2%
Q4 24
7.8%
10.0%
Q3 24
6.6%
5.0%
Q2 24
-31.3%
4.9%
Q1 24
3.2%
17.7%
Net Margin
MD
MD
SNCY
SNCY
Q4 25
6.8%
2.9%
Q3 25
14.5%
0.6%
Q2 25
8.4%
2.5%
Q1 25
4.5%
11.2%
Q4 24
6.1%
5.2%
Q3 24
3.8%
0.9%
Q2 24
-30.3%
0.7%
Q1 24
0.8%
11.3%
EPS (diluted)
MD
MD
SNCY
SNCY
Q4 25
$0.40
$0.15
Q3 25
$0.84
$0.03
Q2 25
$0.46
$0.12
Q1 25
$0.24
$0.66
Q4 24
$0.37
$0.25
Q3 24
$0.23
$0.04
Q2 24
$-1.84
$0.03
Q1 24
$0.05
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
SNCY
SNCY
Cash + ST InvestmentsLiquidity on hand
$375.2M
$234.3M
Total DebtLower is stronger
$570.5M
$323.3M
Stockholders' EquityBook value
$865.9M
$625.2M
Total Assets
$2.2B
$1.7B
Debt / EquityLower = less leverage
0.66×
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
SNCY
SNCY
Q4 25
$375.2M
$234.3M
Q3 25
$340.1M
$176.2M
Q2 25
$224.7M
$138.3M
Q1 25
$99.0M
$158.8M
Q4 24
$229.9M
$187.3M
Q3 24
$103.8M
$146.5M
Q2 24
$19.4M
$135.2M
Q1 24
$8.0M
$161.2M
Total Debt
MD
MD
SNCY
SNCY
Q4 25
$570.5M
$323.3M
Q3 25
$577.2M
$301.3M
Q2 25
$583.9M
$282.1M
Q1 25
$590.5M
$312.6M
Q4 24
$597.1M
$327.1M
Q3 24
$351.8M
Q2 24
$365.5M
Q1 24
$388.1M
Stockholders' Equity
MD
MD
SNCY
SNCY
Q4 25
$865.9M
$625.2M
Q3 25
$890.7M
$610.2M
Q2 25
$833.8M
$613.0M
Q1 25
$789.2M
$603.0M
Q4 24
$764.9M
$570.4M
Q3 24
$732.5M
$552.5M
Q2 24
$706.5M
$546.9M
Q1 24
$856.2M
$541.0M
Total Assets
MD
MD
SNCY
SNCY
Q4 25
$2.2B
$1.7B
Q3 25
$2.2B
$1.6B
Q2 25
$2.1B
$1.6B
Q1 25
$2.0B
$1.6B
Q4 24
$2.2B
$1.6B
Q3 24
$2.1B
$1.6B
Q2 24
$2.0B
$1.6B
Q1 24
$2.2B
$1.6B
Debt / Equity
MD
MD
SNCY
SNCY
Q4 25
0.66×
0.52×
Q3 25
0.65×
0.49×
Q2 25
0.70×
0.46×
Q1 25
0.75×
0.52×
Q4 24
0.78×
0.57×
Q3 24
0.64×
Q2 24
0.67×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
SNCY
SNCY
Operating Cash FlowLast quarter
$114.1M
$78.9M
Free Cash FlowOCF − Capex
$34.9M
FCF MarginFCF / Revenue
12.4%
Capex IntensityCapex / Revenue
15.7%
Cash ConversionOCF / Net Profit
3.39×
9.69×
TTM Free Cash FlowTrailing 4 quarters
$84.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
SNCY
SNCY
Q4 25
$114.1M
$78.9M
Q3 25
$137.3M
$41.9M
Q2 25
$137.2M
$19.8M
Q1 25
$-117.5M
$16.4M
Q4 24
$133.0M
$90.6M
Q3 24
$91.8M
$35.4M
Q2 24
$107.0M
$8.2M
Q1 24
$-125.2M
$30.7M
Free Cash Flow
MD
MD
SNCY
SNCY
Q4 25
$34.9M
Q3 25
$34.0M
Q2 25
$14.0M
Q1 25
$1.0M
Q4 24
$85.8M
Q3 24
$31.0M
Q2 24
$-382.0K
Q1 24
$1.0M
FCF Margin
MD
MD
SNCY
SNCY
Q4 25
12.4%
Q3 25
13.3%
Q2 25
5.3%
Q1 25
0.3%
Q4 24
33.0%
Q3 24
12.4%
Q2 24
-0.2%
Q1 24
0.3%
Capex Intensity
MD
MD
SNCY
SNCY
Q4 25
15.7%
Q3 25
3.1%
Q2 25
2.2%
Q1 25
4.7%
Q4 24
1.8%
Q3 24
1.8%
Q2 24
3.4%
Q1 24
9.5%
Cash Conversion
MD
MD
SNCY
SNCY
Q4 25
3.39×
9.69×
Q3 25
1.91×
27.03×
Q2 25
3.49×
3.01×
Q1 25
-5.66×
0.45×
Q4 24
4.36×
6.74×
Q3 24
4.72×
15.13×
Q2 24
4.50×
Q1 24
-31.03×
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

SNCY
SNCY

Scheduled Service$95.6M34%
Ancillary$69.3M25%
Charter Service$56.6M20%
Cargo And Freight$48.0M17%
Service Other$11.4M4%

Related Comparisons